Suchergebnisse - "Ziepert, Marita"

PubPharm (130)

41

Correction to : IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications

enthalten in: Virchows Archiv : an international journal of pathology | 2020

von Granai, M. | Amato, T. | Di Napoli, A. | +13

ErratumFor: Virchows Arch. 2020 Jul;477(1):143-150. - PMID 31802229

42

IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications

enthalten in: Virchows Archiv : an international journal of pathology | 2020

von Granai, M. | Amato, T. | Di Napoli, A. | +13

ErratumIn: Virchows Arch. 2020 Mar 18;:. - PMID 32189121

43

International prognostic indices in diffuse large B-cell lymphoma : a comparison of IPI, R-IPI, and NCCN-IPI

enthalten in: Blood | 2020

von Ruppert, A. | Dixon, J. | Salles, G. | +11

CommentIn: Blood. 2020 Jun 4;135(23):2014-2015. - PMID 32497224

44

Correction to: IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications

enthalten in: Virchows Archiv | 2020

von Granai, M. | Amato, T. | Di Napoli, A. | +13

45

Correction to: IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications

enthalten in: Virchows Archiv | 2020

von Granai, M. | Amato, T. | Di Napoli, A. | +13

46

Correction to: IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications

enthalten in: Virchows Archiv | 2020

von Granai, M. | Amato, T. | Di Napoli, A. | +13

47

A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL

enthalten in: Leukemia | 2020

von Staiger, A. | Altenbuchinger, M. | Ziepert, M. | +32

48

Low serum albumin is an independent risk factor in elderly patients with aggressive B‐cell lymphoma : Results from prospective trials of the German High‐Grade Non‐Hodgkin's Lymphoma Study Group

enthalten in: eJHaem | 2020

von Hohloch, K. | Ziepert, M. | Truemper, L. | +5

49

Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER) : a randomised, phase 3, non-inferiority trial

enthalten in: Lancet (London, England) | 2019

von Poeschel, V. | Held, G. | Ziepert, M. | +43

CommentIn: Lancet. 2020 Dec 21;394(10216):2208-2209. - PMID 31868615

50

ALK-positive anaplastic large-cell lymphoma in adults : an individual patient data pooled analysis of 263 patients

enthalten in: Haematologica | 2019

von Sibon, D. | Nguyen, D. | Schmitz, N. | +15